Mesangial cell protein kinase C isozyme activation in the diabetic milieu. - Wikidata - wikimedia - TriplyDB

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

http://www.wikidata.org/entity/Q34629037

about

Endothelin and the glomerulus in chronic kidney disease Store-operated calcium entry and diabetic complications Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA Rab34 and its effector munc13-2 constitute a new pathway modulating protein secretion in the cellular response to hyperglycemia Increased hexokinase II expression in the renal glomerulus of mice in response to arsenic High glucose suppresses expression of equilibrative nucleoside transporter 1 (ENT1) in rat cardiac fibroblasts through a mechanism dependent on PKC-zeta and MAP kinases Glibenclamide induces collagen IV catabolism in high glucose-stimulated mesangial cells.Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear factor-kappaB, and activator protein-1 signaling pathways.Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression Activation of protein kinase C isoforms and its impact on diabetic complications.Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience.Changes in the gene expression programs of renal mesangial cells during diabetic nephropathy Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes Physiology and pathology of endothelin-1 in renal mesangium.Canonical transient receptor potential channels in diabetes.Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1.Glucose transporters in diabetic nephropathy.Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species.Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.myo-Inositol Oxygenase Overexpression Accentuates Generation of Reactive Oxygen Species and Exacerbates Cellular Injury following High Glucose Ambience: A NEW MECHANISM RELEVANT TO THE PATHOGENESIS OF DIABETIC NEPHROPATHY Glucotoxicity Induced Oxidative Stress and Inflammation In Vivo and In Vitro in Psammomys obesus: Involvement of Aqueous Extract of Brassica rapa rapifera.Hydrophobic motif site-phosphorylated protein kinase CβII between mTORC2 and Akt regulates high glucose-induced mesangial cell hypertrophy.Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment.A glimpse of various pathogenetic mechanisms of diabetic nephropathy.Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice.Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division.The renal endothelium in diabetic nephropathy.Protein kinase C inhibitors: a patent review (2010 - present).Role of protein kinase C in podocytes and development of glomerular damage in diabetic nephropathy.Increased renal gene transcription of protein kinase C-beta in human diabetic nephropathy: relationship to long-term glycaemic control.PKCdelta regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K.PKC-alpha-mediated remodeling of the actin cytoskeleton is involved in constitutive albumin uptake by proximal tubule cells.Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl.Evidence for a role of protein kinase C-alpha in urine concentration.Protective effect of Lycium barbarum polysaccharide 4 on kidneys in streptozotocin-induced diabetic rats.Stability of actin cytoskeleton and PKC-delta binding to actin regulate NKCC1 function in airway epithelial cells.High glucose inhibits fructose uptake in renal proximal tubule cells: involvement of cAMP, PLC/PKC, p44/42 MAPK, and cPLA2.EGFR-PLCgamma1 signaling mediates high glucose-induced PKCbeta1-Akt activation and collagen I upregulation in mesangial cells.

P2860

Q26828634-4132F683-92A4-445F-BDAD-E721DEB43E02 Q28085037-957CF415-C037-4F9D-BAC7-63B7BB80D54B Q28114829-67D37775-4826-4AAB-AED1-1270DFA594AF Q28116004-BC4A9A5C-6F41-4D47-8FD2-0B54A4F43F77 Q28396987-4794DBCF-9234-475A-8BD5-51F5447AA94B Q28574407-56C017CA-9602-4B9F-8627-3E3B0A57850D Q29347062-0E7452B5-D37F-43FF-A7E7-4F76DA3188AB Q30431563-B6B67D49-F326-484C-A3AF-C2B34DF2479B Q30433969-9B24D034-E0CD-4751-B6A2-336DA52754D7 Q33881442-50D52515-A99C-4310-AD03-CEB10EA5D32B Q33917811-8EE4661D-0F16-40B2-A96C-0EF506B9D1F5 Q34212843-E2E4443F-5772-4C02-86D0-FFB1B1969FFD Q34290697-8896C4FC-47E0-4899-B7BC-0D9F8945F589 Q35098290-B78A9CE5-EF1E-4645-8A08-568861CA004E Q35159419-E4CF5B7E-0B85-4C52-A47E-B57CC9657619 Q35211305-44A236FA-D461-4C64-AEE3-611E5DC53B89 Q35838500-65AB5411-29F1-4C07-92EA-DCA931B1799A Q35857078-60C48A74-8BA6-4249-9316-2266397F61DD Q36045469-EB8BF2A2-86F0-4622-92DE-6EB644D4AD99 Q36062252-54C69266-4105-41F2-87BA-A6627F93C294 Q36256287-984F0216-350A-4DCF-8CF9-A58D2375C3CC Q36674645-6477B62B-EEBC-49B7-B941-4EBF481D58CF Q36707199-08CD5DC1-C2F0-4581-8205-82B88E3D96B1 Q36775718-A83127A4-9BFA-4062-91DC-BDA3DE6416BF Q36785571-AAEA3A36-FBEC-4B56-B31A-F80521ED95D9 Q36979205-83184E2F-1BCA-4AF1-B9BD-952ECBA1B923 Q37399929-7EC6E713-6F15-4C25-B1A5-6C708AD62591 Q37691659-64F79C7B-1BC1-4E21-B472-7CF82180EE05 Q38087656-5A0059EC-843C-44B0-9171-A0AC1F0CC888 Q38116565-D0BC6048-85B8-422F-AECC-8A89F3F11659 Q38270180-FC1C6850-A0FC-4121-8AA5-9F7BAFED3689 Q38427732-D78D8F0C-BE4A-4612-A5D7-1AE5BFA8A3F6 Q40009675-0FAD3218-ECE9-477C-A280-F2C8B1EF27E8 Q40469512-87E4E468-18DA-4099-A809-1F7BD387802D Q42409336-AA9CFBD1-B15E-4C19-9596-4BEC51C13B8F Q42459052-FBEA1DEC-9562-4698-A7C7-1C4C8889D9D4 Q43268880-ECD96D01-0344-481F-BAE8-EF7C39EB25B0 Q44185246-86B245BB-C7F8-416A-8241-F45E75C911D4 Q44979305-BD296745-F5A3-4664-A88D-0A32F6A5BBDF Q45928369-D2780133-29C2-4A1B-97C3-37F069C4CBAA

P2860

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

http://www.wikidata.org/entity/Q34629037

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

@ast

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

@en

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

@nl

type

label

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

@ast

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

@en

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

@nl

prefLabel

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

@ast

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

@en

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

@nl

P1433

Q34629037-139B0B0D-C256-4856-8FE4-08B70B202C0C

P1476

Q34629037-8920DC28-9881-495E-A3A4-DF07A9EB6936

P2093

Q34629037-38EA17E4-B38A-4C2B-884C-D4D4C22D4362

Q34629037-400DB136-364E-4206-AC6A-374248ED1D2F

P2860

Q34629037-0361C526-7EC9-4C4D-B2B1-7CD5D0FC8B1B

Q34629037-041AB160-991A-4968-8FEF-D81E136DFFE0

Q34629037-10D24FD3-17A3-463E-8FF2-71E314299054

Q34629037-227B99E9-316D-46C1-991A-06434AA482AB

Q34629037-26250E62-DB52-420F-87F3-55B56CC0F019

Q34629037-2C4F35DB-B523-4138-A32F-4F09495C6065

Q34629037-32D91AFA-5850-4DE1-9A9D-6AACC39D807A

Q34629037-58EBE188-9873-449A-AAE4-8999E4CC1621

Q34629037-5BF85AC9-6215-4152-8DB5-EB26140B7E61

Q34629037-5D974C72-8E3B-4CF7-B81E-F6BCB479891A

P304

Q34629037-8FAB1EAC-6921-4CF1-B79E-36EA2C167DEF

P31

Q34629037-A7C9004A-EC57-4602-AB60-A150A5E94138

P356

Q34629037-D98835A1-8CE2-448D-A120-B395F6A7190C

P433

Q34629037-D46AF949-B1F5-427A-97A4-7ED58D84417B

P478

Q34629037-F9EF8A85-AD67-44F8-9A2F-FDF5EAFE3C13

P577

Q34629037-AE106FAE-EB09-4A50-9006-3A89A5D51B02

P5875

Q34629037-E2807051-C95E-48CD-B3F9-AE3C64D725E8

P698

Q34629037-D96911B2-B0FA-4564-9072-AD383EF7A5FA

P356

AJPRENAL.00014.2002

P1433

American Journal of Physiology - Renal Physiology

P1476

Mesangial cell protein kinase C isozyme activation in the diabetic milieu.

@en

P2093

Catharine I Whiteside

http://www.w3.org/2001/XMLSchema#string

John A Dlugosz

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Aldose reductase and the role of the polyol pathway in diabetic nephropathy

Requirement for generation of H2O2 for platelet-derived growth factor signal transduction

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

Pharmacologic modulation of protein kinase C isozymes: the role of RACKs and subcellular localisation.

Molecular mechanisms of diabetic renal hypertrophy.

Mitogen-activated protein kinases as glucose transducers for diabetic complications.

Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C.

Identification of PKC-isoform-specific biological actions using pharmacological approaches.

P304

F975-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00014.2002

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

282

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11373999

http://www.w3.org/2001/XMLSchema#string

P698

11997313

http://www.w3.org/2001/XMLSchema#string